Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Theriva Biologics Inc (TOVX)

Theriva Biologics Inc (TOVX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Theriva Biologics Inc 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850 USA

www.therivabio.com Employees: 22 P: 301-417-4364

Sector:

Medical

INDUSTRY GROUPING:

Medical - Drugs

Description:

Theriva Biologics Inc. is a diversified clinical-stage company developing therapeutics designed to treat diseases in areas of high unmet need. The Company's lead candidate includes VCN-01, SYN-004 and SYN-020. Theriva Biologics Inc., formerly known as Synthetic Biologics Inc., is based in ROCKVILLE, Md.

Key Statistics

Overview:

Market Capitalization, $K 6,411
Enterprise Value, $K -5,109
Shares Outstanding, K 33,740
Float, K 33,521
% Float 99.35%
Short Interest, K 5,830
Short Float 17.28%
Days to Cover 1.46
Short Volume Ratio 0.20
% of Insider Shareholders 0.65%
% of Institutional Shareholders 6.17%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -25,650 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -4,360 K
EBIT, $ -26,570 K
EBITDA, $ -20,840 K

Growth:

1-Year Return -86.71%
3-Year Return -99.22%
5-Year Return -99.91%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 92.23%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.45 on 11/12/25
Next Earnings Date 03/05/26 [--]
Earnings Per Share ttm -3.93
EPS Growth vs. Prev Qtr 76.68%
EPS Growth vs. Prev Year 93.39%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-25 on 08/26/24

TOVX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -201.74%
Return-on-Assets % -78.07%
Profit Margin % 0.00%
Debt/Equity 0.24
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 0.69
Book Value/Share 0.29
Interest Coverage -2.47
60-Month Beta 0.56
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar